Geoffery Pharmaceuticals Private Limited
About Geoffery Pharmaceuticals Private Limited
Data last updated:
Geoffery Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 09 November 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51397DL2015PTC287218.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rajender Prashad Bansal and Vishav Deep Bansal.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No.111 Block – I Pocket – 4 Sector – 16 First Floor Rohini, Delhi, India – 110085.
As per the financials filed for FY 2025, the company reported a revenue of ₹23.75 Lakh, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹17.84 Lakh (net margin 75.1%) and EBITDA of ₹22.54 Lakh (EBITDA margin 94.9%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 30% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Geoffery Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressHouse No.111 Block – I Pocket – 4 Sector – 16 First Floor Rohini, Delhi, India – 110085
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Geoffery Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Geoffery Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Geoffery Pharmaceuticals Private Limited, buy the company report.
Financials of Geoffery Pharmaceuticals Private Limited
FY 2025 filings availableGeoffery Pharmaceuticals Private Limited reported revenue of ₹23.75 Lakh (up 7% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 30% over five years, including 7% growth in the latest year. EBITDA rose 37% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹22.54 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹17.84 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 94.9% | ||||
| Net Profit Margin | 75.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Geoffery Pharmaceuticals Private Limited, buy the company report.
Board of directors of Geoffery Pharmaceuticals Private Limited
Geoffery Pharmaceuticals has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajender Prashad Bansal Also directs: Sandoz Biologics LLP, Shell Agro Infrastructure Private Limited, Dee Pharma and Foods Private Limited and 1 more | Director | 07 Sep 2017 | 9 Years 2 Months | Current |
| Vishav Deep Bansal Also directs: Aristo Vetocare LLP | Director | 11 Aug 2025 | 1 Years 2 Months | Current |
Auditor
Geoffery Pharmaceuticals Private Limited is audited by ANKIT S K JAIN & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ANKIT S K JAIN & CO | FY 2022 | 032983N |
Shareholding
The shareholding of Geoffery Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Geoffery Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Geoffery Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Geoffery Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Geoffery Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Geoffery Pharmaceuticals Private Limited has 12 board changes on record since 2015: 7 appointments and 5 cessations. The latest: Santosh Devi Bansal ceased to be Director on 13 Aug 2025.
3 earlier events are in the company report.
Frequently asked questions
Geoffery Pharmaceuticals is an active private limited company based in Delhi, India. The company works in other wholesale, within the trading industry. It was incorporated on 09 November 2015 (11+ years old) and is registered under CIN U51397DL2015PTC287218.
Geoffery Pharmaceuticals has 2 current directors:
- Rajender Prashad Bansal - Director
- Vishav Deep Bansal - Director
The latest financial statements of Geoffery Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2016 are in the company report.
The CIN (Corporate Identification Number) of Geoffery Pharmaceuticals is U51397DL2015PTC287218. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Geoffery Pharmaceuticals was incorporated on 09 November 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
Santosh Devi Bansal ceased to be Director on 13 Aug 2025. Vishav Deep Bansal was appointed as Director on 11 Aug 2025. Santosh Devi Bansal was appointed as Director on 31 Aug 2021. Geoffery Pharmaceuticals has 12 board changes on record in total.
The registered office of Geoffery Pharmaceuticals is at House No.111 Block – I Pocket – 4 Sector – 16 First Floor Rohini, Delhi, India – 110085.
Geoffery Pharmaceuticals operates in the trading industry, in the other wholesale segment.
The compliance status of Geoffery Pharmaceuticals is compliant as of 15 August 2026. The company is actively filing with the Registrar of Companies.
Geoffery Pharmaceuticals can be reached at its registered office: House No.111 Block – I Pocket – 4 Sector – 16 First Floor Rohini, Delhi, India – 110085.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
